Side effects of taking Zanubrutinib

The most common adverse reactions of Zanubrutinib are neutropenia (low levels of neutrophils, a type of white blood cell), upper respiratory tract infection (infection of the nose and throat), bleeding, bruising, rash, and musculoskeletal pain; The most common serious side effects are neutropenia, pneumonia (lung infection), high blood pressure, and thrombocytopenia. Zanubrutinib was generally well tolerated, with generally mild to moderate adverse events generally manageable and not associated with frequent treatment interruptions. In clinical studies of zanubrutinib, warnings and precautions such as bleeding, infection, cytopenias, second primary malignant tumors, arrhythmias, embryo-fetal toxicity, etc. have also emerged.